ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.

Christian VokuhlNasenien Nourkami-TutdibiRhoikos FurtwaenglerManfred GesslerNorbert GrafIvo Leuschner

Published in: Pediatric blood & cancer (2017)

The majority of cellular MNs harbor the ETV6-NTKR3 gene fusion, whereas all classic- and mixed-type MNs were translocation negative. Within the cellular subgroup, patients having translocation-positive tumors had a significantly superior RFS.

Keyphrases

acute lymphoblastic leukemia
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
randomized controlled trial
genome wide
transcription factor
phase iii
study protocol